Welcome to xMAP® Insights. We’ve set out to create a digital magazine that is a collection of inspired and instructive articles that focus on you – our customer. We hope to capture a glimpse into the diverse applications of xMAP® Technology and to spark ideas for your next experiment. Like what you read? Subscribe today to be sure to receive all future issues of xMAP® Insights.
Focus on the use of multispecies xMAP® assays for the medical and agriculture industries.
Focus on the use of multispecies xMAP® assays for the medical and agriculture industries.
Focus on assay development and the tools to help you kickstart your research.
Continued focus on how researchers around the globe have responded to COVID-19.
Focus on the latest in COVID-19 research.
Focus on custom multiplex assay development for cancer research and precision oncology.
Focus on custom multiplex assay development for immunogenicity testing and vaccine development.
Focus on high-throughput biomarker discovery and validation in support of drug discovery and diagnostic development.
Focus on assay development for the detection of infectious diseases.
Focus on proteogenomic applications.
Diasorin Immuno and Molecular product documentation
Dialog 
Licensed Technologies and Luminex products
Product documentation
DiaSorin S.p.A. - Share Capital €55.948.257 R.E.A. 180729 - Fiscal Code and Subscription to Vercelli Companies Register no 13144290155
